Abraham Zangen - Brainsway Director

BWAY Stock  ILA 994.00  6.00  0.60%   

Insider

Abraham Zangen is Director of Brainsway since 2019.
Tenure 5 years
Phone(972) 2 582 4030
Webwww.brainsway.com

Brainsway Management Efficiency

The company has return on total asset (ROA) of (0.0751) % which means that it has lost $0.0751 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.2021) %, meaning that it generated substantial loss on money invested by shareholders. Brainsway's management efficiency ratios could be used to measure how well Brainsway manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 672 K in total debt with debt to equity ratio (D/E) of 0.03, which may suggest the company is not taking enough advantage from borrowing. Brainsway has a current ratio of 9.07, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Brainsway until it has trouble settling it off, either with new capital or with free cash flow. So, Brainsway's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Brainsway sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Brainsway to invest in growth at high rates of return. When we think about Brainsway's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 7 records

INSIDER Age

Yuval MScBio View
62
Sima WeissmanEndymed
59
Yulia CPABio View
41
Yossi CPAEndymed
55
Amir GanunEndymed
49
Joseph LevtzlerEndymed
68
Bill ScottEndymed
N/A
Brainsway Ltd., a commercial stage medical device company, focuses on the development and sale of non-invasive neuromodulation products in Israel and internationally. Brainsway Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel. BRAINSWAY operates under Medical Devices classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 100 people. Brainsway (BWAY) is traded on Tel Aviv Stock Exchange in Israel and employs 118 people.

Management Performance

Brainsway Leadership Team

Elected by the shareholders, the Brainsway's board of directors comprises two types of representatives: Brainsway inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Brainsway. The board's role is to monitor Brainsway's management team and ensure that shareholders' interests are well served. Brainsway's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Brainsway's outside directors are responsible for providing unbiased perspectives on the board's policies.
Avner Lushi, Director
Gavriel Magen, Director
Rami Itselev, Internal Auditor
Karen Sarid, Director
Moria Ankri, VP RD
Hila Rubinshtein, Managing Director of Quality Control
Menachem Esq, Gen VP
Hadar Levy, Senior Vice President, General Manager of North America
Richard Areglado, VP CFO
Christopher Jako, President, Chief Executive Officer
Uri Elmaliach, Director
Abraham Zangen, Director
Daniel Azriel, Director
David Zacut, Chairman of the Board, Interim Chief Executive Officer
Ety Rayten, External Director
Pr Zangen, Member CoFounder
Amit Jino, Clinical Experiment Coordinator
Yosef Shalom, Director
Avner Hagai, Co-Chairman of the Board
Christopher Boyer, Vice President - Global Marketing
Yiftach Roth, Chief Scientific Officer
Aron Tendler, Chief Officer
Ronen Segal, Vice President - Research & Development
Orly Uri, Director
Judith Huber, Chief Financial Officer, Senior Vice President

Brainsway Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Brainsway a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Brainsway

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Brainsway position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Brainsway will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Brainsway could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Brainsway when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Brainsway - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Brainsway to buy it.
The correlation of Brainsway is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Brainsway moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Brainsway moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Brainsway can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Brainsway offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Brainsway's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Brainsway Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Brainsway Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Brainsway. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
For information on how to trade Brainsway Stock refer to our How to Trade Brainsway Stock guide.
You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Complementary Tools for Brainsway Stock analysis

When running Brainsway's price analysis, check to measure Brainsway's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brainsway is operating at the current time. Most of Brainsway's value examination focuses on studying past and present price action to predict the probability of Brainsway's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brainsway's price. Additionally, you may evaluate how the addition of Brainsway to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Transaction History
View history of all your transactions and understand their impact on performance
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Please note, there is a significant difference between Brainsway's value and its price as these two are different measures arrived at by different means. Investors typically determine if Brainsway is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Brainsway's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.